UOC
EDIT icon

UBS O'Connor’s Editas Medicine EDIT Stock Holding History

UBS O'Connor’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,403
Closed -$278K – 572
2024
Q1 		$278K Sell
37,403
-12,597
-25% -$105K 0.01% 377
2023
Q4 		$507K Sell
50,000
-32,369
-39% -$284K 0.02% 346
2023
Q3 		$642K Hold
82,369
– – 0.01% 371
2023
Q2 		$678K Buy
82,369
+18,319
+29% +$160K 0.01% 419
2023
Q1 		$464K Buy
+64,050
New +$569K 0.01% 470

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

UBS O'Connor's EDIT Position: Q2 2024 in Review

UBS O'Connor sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 37,403 shares — an estimated $278K sold.

UBS O'Connor first reported a position in EDIT in Q1 2023 and held it in 5 quarters. The position peaked at $678K in Q2 2023. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • UBS O'Connor reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 37,403 Editas Medicine shares in Q2 2024, an estimated $278K.
  • UBS O'Connor first reported a position in Editas Medicine in Q1 2023 and held it in 5 quarters.
  • UBS O'Connor's Editas Medicine position peaked at $678K in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.